|
EP1654250A1
(en)
*
|
2003-07-25 |
2006-05-10 |
Amgen Inc. |
Substituted pyridones and pyrimidinones with antiinflammatory properties
|
|
EP1656366A1
(en)
|
2003-08-20 |
2006-05-17 |
Amgen Inc. |
Substituted pyrimdinone derivatives and methods of use
|
|
WO2006067531A1
(en)
*
|
2004-12-24 |
2006-06-29 |
Prosidion Ltd |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
|
|
US8062824B2
(en)
*
|
2006-07-17 |
2011-11-22 |
E. I. Du Pont De Nemours And Company |
Thermally imageable dielectric layers, thermal transfer donors and receivers
|
|
US7528448B2
(en)
*
|
2006-07-17 |
2009-05-05 |
E.I. Du Pont De Nemours And Company |
Thin film transistor comprising novel conductor and dielectric compositions
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
CA2696948C
(en)
|
2007-09-14 |
2013-04-30 |
Jose Maria Cid-Nunez |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
|
|
US7666567B2
(en)
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Negative imaging method for providing a patterned metal layer having high conductivity
|
|
US7666568B2
(en)
*
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Composition and method for providing a patterned metal layer having high conductivity
|
|
CA2735764C
(en)
|
2008-09-02 |
2016-06-14 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
BRPI0921333A2
(pt)
|
2008-11-28 |
2015-12-29 |
Addex Pharmaceuticals Sa |
derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
|
|
EA020671B1
(ru)
|
2009-05-12 |
2014-12-30 |
Янссен Фармасьютикалз, Инк. |
ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
|
|
NZ596078A
(en)
|
2009-05-12 |
2013-06-28 |
Janssen Pharmaceuticals Inc |
1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN103298810B
(zh)
|
2010-11-08 |
2016-03-16 |
杨森制药公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
CA2815002C
(en)
|
2010-11-08 |
2019-10-22 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
EP2643320B1
(en)
|
2010-11-08 |
2015-03-04 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
CN103635472B
(zh)
|
2011-02-28 |
2018-01-12 |
阵列生物制药公司 |
丝氨酸/苏氨酸激酶抑制剂
|
|
JP6097289B2
(ja)
|
2011-08-04 |
2017-03-15 |
アレイ バイオファーマ、インコーポレイテッド |
セリン／スレオニンキナーゼインヒビターとしてのキナゾリン化合物
|
|
US9221809B2
(en)
|
2011-10-31 |
2015-12-29 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
WO2013082458A1
(en)
|
2011-12-02 |
2013-06-06 |
The Regents Of The University Of California |
Reperfusion protection solution and uses thereof
|
|
HRP20180591T1
(hr)
|
2012-03-01 |
2018-05-18 |
Array Biopharma, Inc. |
Inhibitori kinaze serina ili treonina
|
|
RU2644947C2
(ru)
|
2012-08-27 |
2018-02-15 |
Аррэй Байофарма Инк. |
Ингибиторы серин/треонин киназы для лечения гиперпролиферативных заболеваний
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
KR102414246B1
(ko)
|
2014-01-21 |
2022-06-27 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
|
LT3431106T
(lt)
|
2014-01-21 |
2021-02-10 |
Janssen Pharmaceutica Nv |
Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
|
|
TWI771402B
(zh)
*
|
2017-04-11 |
2022-07-21 |
日商三井化學Agro股份有限公司 |
吡啶酮化合物及以吡啶酮化合物作為有效成分的農園藝用殺菌劑
|
|
TWI787335B
(zh)
*
|
2017-08-23 |
2022-12-21 |
瑞典商斯普林特生物科技公司 |
吡啶基吡啶酮化合物
|
|
CN116041320A
(zh)
*
|
2017-08-23 |
2023-05-02 |
思普瑞特生物科学公司 |
吡啶胺-吡啶酮化合物和嘧啶胺-吡啶酮化合物
|
|
WO2020163689A1
(en)
|
2019-02-08 |
2020-08-13 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
20-hete formation inhibitors
|
|
EP4251152A1
(en)
|
2020-11-25 |
2023-10-04 |
Deciphera Pharmaceuticals, LLC |
Pyridylpyridone derivatives as vsp34 inhibitors for use in the treatment of a viral infection
|
|
IL314895A
(en)
*
|
2022-02-16 |
2024-10-01 |
Duke Street Bio Ltd |
Pharmaceutical compound
|
|
WO2024119067A1
(en)
|
2022-12-02 |
2024-06-06 |
Neumora Therapeutics, Inc. |
Methods of treating neurological disorders
|